Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

AiCuris Anti-infective Cures GmbH. (12/16/15). "Press Release: J.P. Morgan Healthcare Conference".

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation AiCuris Anti-infective Cures GmbH
  Group STRÜNGMANN Group (family Strüngmann)
  Organisation 2 J.P. Morgan Investment Management Inc.
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 34th Annual Healthcare Conference 2016 San Francisco
  Product 2 anti-infective drug
Persons Person Zimmermann, Holger (AiCuris 201609 CEO before CSO)
  Person 2 Rübsamen-Schaeff, Helga (AiCuris 200603– before Bayer HealthCare anti-infectives research)

Meet AiCuris at J.P. Morgan 34th Annual Healthcare Conference 2016 January 11-14 in San Francisco, CA, USA.

Meet the AiCuris team
Dr. Holger Zimmermann, AiCuris’ Chief Executive Officer Prof. Dr. Helga Rübsamen-Schaeff, Chair of AiCuris’ Scientific Advisory Board

> Get an overview of AiCuris activities in Anti-Infectives drug development

> Discuss recent developments in the Company’s clinical pipeline

> Learn about future opportunities in one of the most important pharmaceutical indications

Contact for meeting opportunities:

AiCuris Anti-infective Cures GmbH
Katja Woestenhemke
T.:+49 202 317 63 - 0

Record changed: 2017-07-02


Picture [iito] – Putting Information into Context 600x60px

More documents for STRÜNGMANN Group (family Strüngmann)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

» top